Sentences with phrase «stem cells centers»

A major concern about stem cells centers on how unstable they can become when grown in the lab.

Sheng Ding, PhD, a senior investigator in the Roddenberry Stem Cell Center at Gladstone and co-senior author on the study, adds, «This new cellular reprogramming and expansion paradigm is more sustainable and scalable than previous methods.

«I routinely see where individual stem cell centers in the United States receive donations from some high - net - worth individuals in the range of $ 50 million — you don't see that happening routinely here in the UK,» says KCL's Minger, an American who moved to the UK about 13 years ago.

«A stem cell's job is twofold: to replace or recreate mature cells that are lost over time, both through normal aging and after injury, and to replace themselves so that the process can continue over the life of the animal,» said senior author John Ngai, the Coates Family Professor of Neuroscience and a member of UC Berkeley's Helen Wills Neuroscience Institute and the Berkeley Stem Cell Center.

Moderated by: Philip Campbell, Editor - in - Chief, Nature and the Nature - branded publications Günter M. Ziegler, Professor, Freie Universität Berlin Dame Julia Higgins, former Vice President and Foreign Secretary of the Royal Society Yee Cheong Lee, Chairman of Governing Board, International Science, Technology and Innovation Centre for South - South Cooperation under the auspices of UNESCO (ISTIC) Rana Dajani, Associate Professor Hashemite University, Jordan; Visiting Professor, Yale Stem Cell Center and University of Cambridge

Srivastava, who pioneered the use of stem cells for heart disease, is director of the Roddenberry Stem Cell Center and a senior investigator at the Gladstone Institutes.

Moderated by: Hossam Badrawi, Chairman Nile Badrawi Foundation for Education & Development, former Chairman of the Committee on Education and Scientific Research, Parliament of Egypt Ernesto Fernandez Polcuch, Senior Programme Specialist Natural Sciences, UNESCO Aicha Bammoun, Programme Specialist, Science Directorate, ISESCO Paul Rübig, Chair, European Parliament's Science and Technology Options Assessment (STOA) Liliya Hrynevych, Chairperson, Committee on Science and Education, Parliament of Ukraine Jesus Hurtado, Member of the Commission on Science, Innovation and Technology, Congress of the Republic Peru Ninlawan Petcharaburanin, Advisor for the Committee on Science Technology National Assembly, Thailand Rana Dajani, Associate Professor, Hashemite University, Jordan; Visiting Professor, Yale Stem Cell Center and University of Cambridge

President, Gladstone Institutes Director, Roddenberry Stem Cell Center Senior Investigator & Director, Gladstone Institute of Cardiovascular Disease

«Lorenz has already made great strides in his quest to translate his findings to the clinic,» said Deepak Srivastava, MD, director of the Roddenberry Stem Cell Center at the Gladstone Institutes, and member of the prize's selection committee.

Deepak Srivastava, MD Director of the Gladstone Institute of Cardiovascular Disease and Director of the Roddenberry Stem Cell Center, Gladstone Institutes

This grim prospect is what stem cell scientists, like Dr. Deepak Srivastava, Director of Cardiovascular Disease and the Stem Cell Center at the Gladstone Institutes in San Francisco, are hoping to change.

In 2007, he became a senior investigator at Gladstone, where he currently conducts his research at the Roddenberry Stem Cell Center.

Very interesting article... I find myself amazed at how much work one or two labs can churn out to advance our understanding — Perhaps you could do a post on current Stem Cell centers around the world, and how much man - power and budget is being devoted to them?

«It is extremely gratifying to see iPS cell technology applied in humans only eight years after its discovery,» says Shinya Yamanaka, MD, PhD, a senior investigator at the Gladstone Institutes and member of the Roddenberry Stem Cell Center at Gladstone.

«We were amazed by the dramatic difference in performance between the two systems,» said senior author Bruce Conklin, MD, a senior investigator in the Gladstone Institute of Cardiovascular Disease and Roddenberry Stem Cell Center at Gladstone.

At Gladstone, he conducts research at the Roddenberry Stem Cell Center.

Dr. Deepak Srivastava, director of the Gladstone Institute of Cardiovascular Disease and director of the Roddenberry Stem Cell Center at Gladstone, says that advances in stem cell technology may one day help us cure heart disease.

The Roddenberry Stem Cell Center at the Gladstone Institutes is an international powerhouse in stem cell research.

The stem cell center, headed by Sue O'Shea, Ph.D., is based in the U-M Medical School's Department of Cell and Developmental Biology.

Dr. Tjian joined the University of California, Berkeley faculty in 1979, where he assumed several leadership roles such as: Director of the Berkeley Stem Cell Center, Faculty Director of the Li Ka Shing Center for Biomedical and Health Sciences and Head of the Siebel Stem Initiative.

Significant interdisciplinary research in stem cells is being performed at UC Santa Barbara, by a team of neurobiologists and physicists, with assistance from scientists at Harvard Medical School, UCLA's Geffen School of Medicine, and the Yale Stem Cell Center.

Neurona's Board of Directors includes: Tim Kutzkey, PhD, interim Chief Executive Officer of Neurona and Partner at The Column Group; David Goeddel, PhD, Managing Partner at The Column Group; Leo Guthart, PhD, Founder and Senior Advisor at Topspin Partners; Arnold Kriegstein, MD, PhD, Co-Founder, Professor of Neurology and Director of the stem cell center at UCSF; and Stephen Hauser, MD, Chair of Neurology at UCSF.

Funding: This work was supported by the Keck School of Medicine, University of Southern California, and the Australian Stem Cell Center.

Dean Carmen A. Puliafito, M.D., M.B.A., lauded Eli and Edythe Broad and CIRM for their generous leadership in making the new stem cell center possible.

The Eli and Edythe Broad Foundation has given $ 75 million to fund three stem cell centers in California: the Eli and Edythe Broad CIRM Center for Regenerative Medicine and Stem Cell Research at USC, the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA and the Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research at UCSF.

The Broad Foundation is the largest nongovernmental donor to stem cell research in California, having given $ 75 million to support or create stem cell centers at UCSF, USC and UCLA.

Not exact matches

C. Anthony Blau, M.D., Professor of Medicine, Division of Hematology, Co-Director, Institute for Stem Cell and Regenerative Medicine; Director, Center for Cancer Innovation, University of Washington School of Medicine; Founder, All4Cure

A research group at Cincinnati Children's Hospital Medical Center used human pluripotent stem cells (hPSCs) to grow human stomach tissue (paywall)-- and, notably, the part of the organ that produces digestive enzymes.

According to Stanford Medicine Ludwig Center, «cancer stem cells are similar to weeds in a garden — if their roots aren't taken out, the weeds are able to grow back».

In 2010, researchers from the University of Michigan Comprehensive Cancer Center published a study in the journal Clinical Cancer Research showing that sulforaphane had the ability to kill breast cancer stem cells in mice and in lab cultures, and it also prevented the growth of new tumor cells.

One of the best talks of this conference was given by Dr. Renee Reijo Pera, Professor and Director of the Center for Human Embryonic Stem Cell Research at Stanford University.

Numerous smaller nonprofits, such as the Robert Packard Center for ALS Research and the Australian Stem Cell Centre, to name two, have a specific biomedical focus.

In a groundbreaking study that provides scientists with a critical new understanding of stem cell development and its role in disease, UCLA researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research led by Dr. Kathrin Plath, professor of biological chemistry, have established a first - of - its - kind methodology that defines the unique stages by which specialized cells are reprogrammed into stem cells that resemble those found in the embstem cell development and its role in disease, UCLA researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research led by Dr. Kathrin Plath, professor of biological chemistry, have established a first - of - its - kind methodology that defines the unique stages by which specialized cells are reprogrammed into stem cells that resemble those found in the embcell development and its role in disease, UCLA researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research led by Dr. Kathrin Plath, professor of biological chemistry, have established a first - of - its - kind methodology that defines the unique stages by which specialized cells are reprogrammed into stem cells that resemble those found in the embStem Cell Research led by Dr. Kathrin Plath, professor of biological chemistry, have established a first - of - its - kind methodology that defines the unique stages by which specialized cells are reprogrammed into stem cells that resemble those found in the embCell Research led by Dr. Kathrin Plath, professor of biological chemistry, have established a first - of - its - kind methodology that defines the unique stages by which specialized cells are reprogrammed into stem cells that resemble those found in the embstem cells that resemble those found in the embryo.

The discovery is an important advance in the search for new medications to fight obesity, said senior investigator Shingo Kajimura, PhD, UCSF assistant professor of cell and tissue biology, with a joint appointment in the UCSF Diabetes Center and the Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research at Ucell and tissue biology, with a joint appointment in the UCSF Diabetes Center and the Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research at UCell Research at UCSF.

Researchers at Rush University Medical Center are exploring a new therapy using stem cells to treat spinal cord injuries within the first 14 to 30 days of injury.

Led by researchers at the Cincinnati Children's Hospital Medical Center Heart Institute, the study demonstrates the gene Gm7325 and its protein — which the scientists named «myomerger» — prompt muscle stem cells to fuse and develop skeletal muscles the body needs to move and survive.

«Several major advances in recent years have been good news for multiple myeloma patients, but those new drugs only target terminally differentiated cancer cells and thus can only reduce the bulk of the tumor,» said Jamieson, who is also deputy director of the Sanford Stem Cell Clinical Center, director of the CIRM Alpha Stem Cell Clinic at UC San Diego and director of stem cell research at Moores Cancer Center at UC San Diego HeaStem Cell Clinical Center, director of the CIRM Alpha Stem Cell Clinic at UC San Diego and director of stem cell research at Moores Cancer Center at UC San Diego HeaCell Clinical Center, director of the CIRM Alpha Stem Cell Clinic at UC San Diego and director of stem cell research at Moores Cancer Center at UC San Diego HeaStem Cell Clinic at UC San Diego and director of stem cell research at Moores Cancer Center at UC San Diego HeaCell Clinic at UC San Diego and director of stem cell research at Moores Cancer Center at UC San Diego Heastem cell research at Moores Cancer Center at UC San Diego Heacell research at Moores Cancer Center at UC San Diego Health.

«I think this is the best option we have ever had,» says Renee Reijo Pera, director of Stanford University's Center for Human Embryonic Stem Cell Research and Education in California, who wasn't involved in the study.

In the context of the collaboration between the Gates Center for Stem Cell Biology and the CU Cancer Center this was the second clinical trial we offered to our patients with the specific intent to eliminate the CSCs in their tumors.»

Yoshiki Sasai at the RIKEN Center for Developmental Biology in Kobe, Japan, and colleagues encouraged embryonic stem cells to develop into retinal cells, and then grew them alongside a protein matrix to promote the formation of tissue.

That risk is currently a hurdle in many stem cell therapies, says Curt Freed of the University of Colorado Health Sciences Center in Denver.

They focused on the stomach both because Mills is co-director of Washington University's NIH - supported Digestive Disease Center and because the anatomy in the stomach makes it easier to distinguish stem cells from mature cells that perform specific tasks.

«These are optimistic results for one of the first targeted therapies for cancer stem cells,» says Antonio Jimeno, MD, PhD, investigator at the CU Cancer Center, director of the university's Cancer Stem Cell - Directed Clinical Trials Program, and principal investigator of the clinical trial at the CU Cancer Center sstem cells,» says Antonio Jimeno, MD, PhD, investigator at the CU Cancer Center, director of the university's Cancer Stem Cell - Directed Clinical Trials Program, and principal investigator of the clinical trial at the CU Cancer Center sStem Cell - Directed Clinical Trials Program, and principal investigator of the clinical trial at the CU Cancer Center site.

In collaboration with Prof. Dr. Roland Schüle and his team at the Center of Clinical Research of the Freiburg University Medical Center, the scientists were able to test several epigenetic inhibitors that had been newly developed by Schüle and his team on the cancer stem cell model.

«We have identified a code of «molecular switches» that control a very aggressive subpopulation of brain cancer cells, so - called glioblastoma stem cells,» says Mario Suvà, MD, PhD, of the MGH Department of Pathology and Center for Cancer Research, co-lead author of the Cell article.

Researchers at Dana - Farber / Boston Children's Cancer and Blood Disorders Center report promising outcomes from a clinical trial with patients with a rare form of bone marrow failure who received a hematopoietic stem cell transplant (HSCT) after pre-treatment with immunosuppressive drugs only.

Shane Mayack was a postdoc in the lab of Amy Wagers at Harvard University's Joslin Diabetes Center, studying blood stem cells.

Similar limbal stem cell transplant work has been done by physicians at the University of Melbourne's Center for Eye Research Australia and the Bernard O'Brien Institute of Microsurgery in Fitzroy, Australia.

Sean Morrison, director of the Center for Stem Cell Biology at the University of Michigan at Ann Arbor, pointed out that pitting different kinds of stem cell research against each other makes little sense from a research perspectStem Cell Biology at the University of Michigan at Ann Arbor, pointed out that pitting different kinds of stem cell research against each other makes little sense from a research perspectCell Biology at the University of Michigan at Ann Arbor, pointed out that pitting different kinds of stem cell research against each other makes little sense from a research perspectstem cell research against each other makes little sense from a research perspectcell research against each other makes little sense from a research perspective.

«This work demonstrates the feasibility of using a single gene editing platform, plus the regenerative power of stem cells to correct genetic mutations and restore dystrophin production for 60 percent of Duchenne patients,» said Pyle, associate professor of microbiology, immunology and molecular genetics and member of the Broad Stem Cell Research Censtem cells to correct genetic mutations and restore dystrophin production for 60 percent of Duchenne patients,» said Pyle, associate professor of microbiology, immunology and molecular genetics and member of the Broad Stem Cell Research CenStem Cell Research Center.